Evidence map›Paper›PMID 41104957›Full record

ArticleInvestigative ophthalmology & visual science2025

Measuring Rod- and Cone-Photoreceptor-Specific Vision in Inherited Retinal Diseases Using a Commercial Perimeter.

Vivian Wu, Alejandro J Roman, Emma L Galsterer, Georg Ansari, Inbar Erdinest, Giulia Righetti, Iryna Viarbitskaya, Robert C Russell, Rebecca J Kim, Jacques Charlier and 7 more

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Vivian WuCenter for Hereditary Retinal Degenerations, Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Alejandro J RomanCenter for Hereditary Retinal Degenerations, Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Emma L GalstererUniversity Eye Hospital, Center for Ophthalmology, University of Tübingen, Tübingen, Germany.
Georg AnsariDepartment of Ophthalmology, University of Basel, Basel, Switzerland.
Inbar ErdinestCenter for Retinal and Macular Degenerations, Department of Ophthalmology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Giulia RighettiUniversity Eye Hospital, Center for Ophthalmology, University of Tübingen, Tübingen, Germany.
Iryna ViarbitskayaCenter for Hereditary Retinal Degenerations, Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Robert C RussellCenter for Hereditary Retinal Degenerations, Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Rebecca J KimCenter for Hereditary Retinal Degenerations, Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Jacques CharlierMetrovision, Perenchies, France.
Kristina PfauDepartment of Ophthalmology, University of Basel, Basel, Switzerland.
Krunoslav StinglUniversity Eye Hospital, Center for Ophthalmology, University of Tübingen, Tübingen, Germany.
Eyal BaninCenter for Retinal and Macular Degenerations, Department of Ophthalmology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Maximilian PfauDepartment of Ophthalmology, University of Basel, Basel, Switzerland.
Katarina StinglUniversity Eye Hospital, Center for Ophthalmology, University of Tübingen, Tübingen, Germany.
Tomas S AlemanCenter for Hereditary Retinal Degenerations, Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Artur V CideciyanCenter for Hereditary Retinal Degenerations, Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The primary pathology in most inherited retinal diseases (IRDs) is located within photoreceptors. Standard automatic perimetry (SAP) can measure photoreceptor disease severity but cannot distinguish between rods, long/middle-wavelength (L/M)-sensitive, and short-wavelength (S)-sensitive cones. Herein we developed a protocol that can provide photoreceptor-specific sensitivities. Methods: A commercial (unmodified) perimeter was used to develop a clinical protocol that includes five profiles along the vertical meridian, utilizing different chromatic stimuli presented in the dark-adapted state or on adapting backgrounds. Data were recorded by the Perimetry for IRD (PERIRD) consortium in control participants and patients with IRDs. Results: The protocol was developed by evaluating the relationship between chromatic thresholds and adapting backgrounds using a threshold-versus-intensity paradigm. Five conditions were selected: two-color dark-adapted, red-on-blue, and blue-on-yellow tests in addition to white-on-white SAP. Prediction intervals from control eyes were defined, and physiological ranges over which rod-, L/M-, and S-cone-specific results can be obtained were estimated. Testing in complete achromatopsia, blue-cone monochromacy, and enhanced S-cone syndrome confirmed classic patterns expected from cone diseases. Patients with incomplete achromatopsia showed partially retained L/M- or S-cone function. Patients with retinitis pigmentosa demonstrated use of photoreceptor-specific function to interpret different disease subtypes and stages. Total test time for the protocol was usually under 30 minutes. Conclusions: Photoreceptor-specific function can be measured over a large dynamic range using a turnkey commercial perimeter and a relatively short, practical protocol that may be introduced into the clinic, translational work, and clinical trials.

Indexed as

Retinal Cone Photoreceptor CellsRetinal DiseasesRetinal Rod Photoreceptor CellsVisual FieldsVisual Field TestsAdolescentAdultChildColor Vision DefectsDark AdaptationFemaleHumansMaleMiddle AgedYoung Adult

Identifiers

PMID41104957
PMCPMC12534894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.